載入...
Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia
BACKGROUND: Levodopa‐carbidopa intestinal gel (LCIG) treatment has shown variable effect on dyskinesia in Parkinson's disease (PD). OBJECTIVE: To identify PD patients who are likely to have troublesome dyskinesia under LCIG treatment and describe the pharmacokinetic‐dynamic profile and dyskines...
Na minha lista:
| 發表在: | Mov Disord Clin Pract |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604637/ https://ncbi.nlm.nih.gov/pubmed/33163564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.13068 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|